Safety and Efficacy of CD19/CD22 Dual Targeted CAR-T Cell Therapy in Patients With R/R B-Cell Acute Lymphoblastic Leukemia

Study Summary

This is an open, single-arm, prospective clinical study to evaluate the safety and efficacy of anti CD19 and CD22 CAR-T cell in the treatment of R/R B-ALL.

Interventions

Study Locations

Facility	City	State	Country
Hebei Yanda Ludaopei Hospital	Langfang	Hebei	China

Official Trial Information

View on ClinicalTrials.gov